Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × Laser Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Precancerous Conditions 1 Papilloma 1 Lung Neoplasms 1 Laryngeal papillomatosis 1 Keratosis, Actinic 1 Hyperthermia 1 Head and Neck Neoplasms 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Temozolomide 21 Bevacizumab 10 Radiotherapy 5 Irinotecan 5 Carmustine 4 Topotecan 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Carboplatin 3 Aminolevulinic Acid 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 fluorodopa F 18 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 TIC10 compound 2 Surgical Procedures, Operative 2 Standard of Care 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2 Filgrastim 2 Erlotinib Hydrochloride 2 Dynamic Contrast Enhanced Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515085 2014-05-22

LITT

Rutgers, The State University of New Jersey

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡